NEW YORK – Researchers used patient-derived organoids to test the activity of different drugs, and based on the results, changed treatments for two metastatic colorectal cancer patients, according to a recently published study.
NEW YORK – Researchers used patient-derived organoids to test the activity of different drugs, and based on the results, changed treatments for two metastatic colorectal cancer patients, according to a recently published study.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.